Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Oct 7, 2004

 

BioCommerce Week’s Index to the Diversified Molecular Biology Tools Companies

On a week when Merck withdrew its anti-inflammatory medicine Vioxx from the market, the BioCommerce Week Index of Diversified Molecular Biology Tools Companies recovered from last week’s 3-percent fall, registering a 2-percent gain for the weekly period ending Tuesday.

This index of 15 companies has recorded gains in three out of the four weeks since it was introduced.

While the Amex Pharmaceutical Index was down 1 percent for the week, the Amex biotechnology index recorded a 2-percent gain for the five-day period. The Dow Jones Industrial Average was up about 1 percent for the week, the S&P 500 improved better than 2 percent, while the Nasdaq composite index finished above 4 percent for the week.

Agilent, last week’s loser with an 8 percent drop, led 14 BCW Index gainers with a 9-percent improvement, closing at $23.21 Tuesday, compared to a $21.29 close last week. Applied Biosystems and Stratagene each recorded 5 percent gains, while Molecular Devices, Thermo Electron, PerkinElmer, and Bio-Rad each had 4-percent gains.

Bruker was the only company falling, dropping to $3.31 from last week’s close of $3.52.

Following is a list of when the BCW Index companies will report their financials for the quarter ended Sept. 30:

  • Agilent, Q4 2004: Nov. 11, 2004
  • Applied Biosystems, Q1 2005: Oct. 25, 2004
  • Becton Dickinson, Q4 2004: Nov. 4, 2004
  • Beckman Coulter, Q3 2004: Nov. 4, 2004
  • Bio-Rad, Q3 2004: Nov. 1, 2004
  • Bruker, Q3 2004: Nov. 1, 2004
  • General Electric, Q3 2004: Oct. 8, 2004
  • Harvard Biosciences, Q3 2004: Oct. 25, 2004
  • Invitrogen, Q3 2004: Oct. 25, 2004
  • Molecular Devices, Q3 2004: no date set
  • PerkinElmer, Q3 2004: Oct. 18, 2004,
  • Sigma-Aldrich, Q3 2004: Oct. 21, 2004
  • Stratagene, Q3 2004: Nov. 8, 2004
  • Thermo, Q2 2004: no date set
  • Waters, Q3 2004: Oct. 25, 2004
File Attachments
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.